These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7820186)

  • 21. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation.
    Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ
    Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.
    Beall HD; Sloan KB
    Int J Pharm; 2002 Jan; 231(1):43-9. PubMed ID: 11719012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum.
    Singh BN; Singh RB; Singh J
    Int J Pharm; 2005 Jul; 298(1):98-107. PubMed ID: 15913928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
    Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1780-1791. PubMed ID: 28581826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney- and site-selective delivery of 5-fluorouracil utilizing the absorption on the kidney surface in rats.
    Kawakami S; Horimoto T; Nishida K; Hirayama R; Mukai T; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
    Biol Pharm Bull; 2002 Jul; 25(7):928-30. PubMed ID: 12132672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies on the kidney- and site-selective delivery of 5-fluorouracil following kidney surface application in rats.
    Nakamura J; Horimoto T; Hirayama R; Mukai T; Nakashima M; Sasaki H; Nishida K
    Biol Pharm Bull; 2003 Dec; 26(12):1761-4. PubMed ID: 14646186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
    Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
    Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
    Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
    J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro and in-vivo assessment of dextran-appended cellulose acetate phthalate nanoparticles for transdermal delivery of 5-fluorouracil.
    Garg A; Rai G; Lodhi S; Jain AP; Yadav AK
    Drug Deliv; 2016 Jun; 23(5):1525-35. PubMed ID: 25417834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil.
    Gómez C; Costela A; García-Moreno I; Llanes F; Teijón JM; Blanco D
    Lasers Surg Med; 2008 Jan; 40(1):6-12. PubMed ID: 18220260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
    Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.
    Khallaf RA; Salem HF; Abdelbary A
    Drug Deliv; 2016 Nov; 23(9):3452-3460. PubMed ID: 27240935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption and distribution characteristics of 5-fluorouracil (5-FU) after an application to the liver surface in rats in order to reduce systemic side effects.
    Kodama Y; Fumoto S; Nishi J; Nakashima M; Sasaki H; Nakamura J; Nishida K
    Biol Pharm Bull; 2008 May; 31(5):1049-52. PubMed ID: 18451546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers.
    Mutalik S; Shetty PK; Kumar A; Kalra R; Parekh HS
    Drug Deliv; 2014 Feb; 21(1):44-54. PubMed ID: 24134794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres.
    Chiang CH; Tung SM; Lu DW; Yeh MK
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):545-53. PubMed ID: 11777178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.